| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Clearance of Tritrichomonas foetus in experimentally infected heifers protected with vaccines based on killed-T. foetus with different adjuvants
|
Fuchs, Lumila I.
|
|
2017
|
35 |
9 |
p. 1341-1346
6 p.
|
artikel
|
| 2 |
Comparison of platform technologies for assaying antibody to Ebola virus
|
Wilkinson, Dianna E.
|
|
2017
|
35 |
9 |
p. 1347-1352
6 p.
|
artikel
|
| 3 |
Control of infestations by Ixodes ricinus tick larvae in rabbits vaccinated with aquaporin recombinant antigens
|
Contreras, Marinela
|
|
2017
|
35 |
9 |
p. 1323-1328
6 p.
|
artikel
|
| 4 |
Dengue vaccine: WHO position paper, July 2016 – recommendations
|
World Health Organization,
|
|
2017
|
35 |
9 |
p. 1200-1201
2 p.
|
artikel
|
| 5 |
Development of a single-dose recombinant CAMP factor entrapping poly(lactide-co-glycolide) microspheres-based vaccine against Streptococcus agalactiae
|
Liu, Gang
|
|
2017
|
35 |
9 |
p. 1246-1253
8 p.
|
artikel
|
| 6 |
Early sexual debut warrants HPV vaccination at an earlier age
|
Berenson, Abbey B.
|
|
2017
|
35 |
9 |
p. 1195-1196
2 p.
|
artikel
|
| 7 |
Editorial Board/Aims and Scope
|
|
|
2017
|
35 |
9 |
p. IFC-
1 p.
|
artikel
|
| 8 |
Effectiveness of a commercial leptospiral vaccine on urinary shedding in naturally exposed sheep in New Zealand
|
Vallée, Emilie
|
|
2017
|
35 |
9 |
p. 1362-1368
7 p.
|
artikel
|
| 9 |
Efficacy of clade 2.3.2 H5 commercial vaccines in protecting chickens from clade 2.3.4.4 H5N8 highly pathogenic avian influenza infection
|
Yuk, Seong-su
|
|
2017
|
35 |
9 |
p. 1316-1322
7 p.
|
artikel
|
| 10 |
Exploratory efficacy endpoints in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)
|
Webber, Chris
|
|
2017
|
35 |
9 |
p. 1266-1272
7 p.
|
artikel
|
| 11 |
IL-17A and complement contribute to killing of pneumococci following immunization with a pneumococcal whole cell vaccine
|
Campos, Ivana B.
|
|
2017
|
35 |
9 |
p. 1306-1315
10 p.
|
artikel
|
| 12 |
Impact of vaccination on influenza mortality in children <5years old in Mexico
|
Sánchez-Ramos, Evelyn L.
|
|
2017
|
35 |
9 |
p. 1287-1292
6 p.
|
artikel
|
| 13 |
Integration of data from a safety net health care system into the Vaccine Safety Datalink
|
Hambidge, Simon J.
|
|
2017
|
35 |
9 |
p. 1329-1334
6 p.
|
artikel
|
| 14 |
Introduction of inactivated poliovirus vaccine leading into the polio eradication endgame strategic plan; Hangzhou, China, 2010–2014
|
Liu, Yan
|
|
2017
|
35 |
9 |
p. 1281-1286
6 p.
|
artikel
|
| 15 |
Is this thing on? Getting the public to listen to the pro-vaccine message
|
Goldstein, Neal D.
|
|
2017
|
35 |
9 |
p. 1208-
1 p.
|
artikel
|
| 16 |
Metabolites as biomarkers of adverse reactions following vaccination: A pilot study using nuclear magnetic resonance metabolomics
|
McClenathan, Bruce M.
|
|
2017
|
35 |
9 |
p. 1238-1245
8 p.
|
artikel
|
| 17 |
Microarray profile of the humoral immune response to influenza vaccination in breast cancer patients treated with chemotherapy
|
Wumkes, M.L.
|
|
2017
|
35 |
9 |
p. 1299-1305
7 p.
|
artikel
|
| 18 |
Mucosal vaccination promotes clearance of Streptococcus agalactiae vaginal colonization
|
Baker, Jacqueline A.
|
|
2017
|
35 |
9 |
p. 1273-1280
8 p.
|
artikel
|
| 19 |
On the need to wait 4 weeks between two live attenuated vaccines
|
Camacho, Luiz Antonio Bastos
|
|
2017
|
35 |
9 |
p. 1207-
1 p.
|
artikel
|
| 20 |
Placebo use in vaccine trials: Caution when using active vaccines as placebo
|
Byberg, Stine
|
|
2017
|
35 |
9 |
p. 1211-
1 p.
|
artikel
|
| 21 |
Polio eradication in the African Region on course despite public health emergencies
|
Okeibunor, Joseph C.
|
|
2017
|
35 |
9 |
p. 1202-1206
5 p.
|
artikel
|
| 22 |
Polio vaccines: WHO position paper, March 2016–recommendations
|
World Health Organization,
|
|
2017
|
35 |
9 |
p. 1197-1199
3 p.
|
artikel
|
| 23 |
Recommendations and offers for adult influenza vaccination, 2011–2012 season, United States
|
Benedict, Katharine M.
|
|
2017
|
35 |
9 |
p. 1353-1361
9 p.
|
artikel
|
| 24 |
Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation – A systematic review of randomized trials, observational studies and case reports
|
Croce, Evelina
|
|
2017
|
35 |
9 |
p. 1216-1226
11 p.
|
artikel
|
| 25 |
Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2–49years
|
Baxter, Roger
|
|
2017
|
35 |
9 |
p. 1254-1258
5 p.
|
artikel
|
| 26 |
The rise and fall of pneumococcal serotypes carried in the PCV era
|
Devine, Vanessa T.
|
|
2017
|
35 |
9 |
p. 1293-1298
6 p.
|
artikel
|
| 27 |
Tick-borne encephalitis in China: A review of epidemiology and vaccines
|
Xing, Yi
|
|
2017
|
35 |
9 |
p. 1227-1237
11 p.
|
artikel
|
| 28 |
US medical students’ willingness to offer the HPV vaccine by vaccination status
|
Berenson, Abbey B.
|
|
2017
|
35 |
9 |
p. 1212-1215
4 p.
|
artikel
|
| 29 |
Vaccine adverse events in a safety net healthcare system and a managed care organization
|
Narwaney, Komal J.
|
|
2017
|
35 |
9 |
p. 1335-1340
6 p.
|
artikel
|
| 30 |
Vaccine draining lymph nodes are a source of antigen-specific B cells
|
Pero, Stephanie C.
|
|
2017
|
35 |
9 |
p. 1259-1265
7 p.
|
artikel
|
| 31 |
When vaccine hesitancy makes headlines
|
Odone, A.
|
|
2017
|
35 |
9 |
p. 1209-1210
2 p.
|
artikel
|
Tijdschrift beschrijving